178 related articles for article (PubMed ID: 27743408)
1. Pharmacokinetics of ivermectin applied topically by whole-body bathing method in healthy volunteers.
Miyajima A; Hirota T; Tashiro M; Noguchi W; Kawano Y; Hanawa T; Kigure A; Anata T; Yamamoto Y; Yuasa N; Koshino M; Shiraishi Y; Yuzawa K; Akagi K; Yoshimasu T; Makigami K; Komoda M
J Dermatol; 2017 Apr; 44(4):406-413. PubMed ID: 27743408
[TBL] [Abstract][Full Text] [Related]
2. Experimental study of pharmacokinetics of external, whole-body bathing application of ivermectin.
Miyajima A; Komoda M; Akagi K; Yuzawa K; Yoshimasu T; Yamamoto Y; Hirota T
J Dermatol; 2015 Jan; 42(1):87-9. PubMed ID: 25492083
[TBL] [Abstract][Full Text] [Related]
3. Effect of high-fat meal intake on the pharmacokinetic profile of ivermectin in Japanese patients with scabies.
Miyajima A; Hirota T; Sugioka A; Fukuzawa M; Sekine M; Yamamoto Y; Yoshimasu T; Kigure A; Anata T; Noguchi W; Akagi K; Komoda M
J Dermatol; 2016 Sep; 43(9):1030-6. PubMed ID: 26918286
[TBL] [Abstract][Full Text] [Related]
4. Mechanism for transport of ivermectin to the stratum corneum in rats.
Miyajima A; Kigure A; Anata T; Hirota T
Drug Metab Pharmacokinet; 2015 Dec; 30(6):385-90. PubMed ID: 26613804
[TBL] [Abstract][Full Text] [Related]
5. Case series of elderly patients with scabies topically applied with ivermectin via whole-body bathing.
Komoda M; Miyajima A; Koshino M; Akutsu S; Yamada M; Ozeki R; Makigami K
J Dermatol; 2021 Apr; 48(4):559-563. PubMed ID: 33410137
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers.
Duthaler U; Suenderhauf C; Karlsson MO; Hussner J; Meyer Zu Schwabedissen H; Krähenbühl S; Hammann F
Br J Clin Pharmacol; 2019 Mar; 85(3):626-633. PubMed ID: 30566757
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies.
Chhaiya SB; Patel VJ; Dave JN; Mehta DS; Shah HA
Indian J Dermatol Venereol Leprol; 2012; 78(5):605-10. PubMed ID: 22960817
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies.
Ahmad HM; Abdel-Azim ES; Abdel-Aziz RT
Dermatol Ther; 2016; 29(1):58-63. PubMed ID: 26555785
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Human Scabies with Oral Ivermectin. Eczematous Eruptions as a New Non-Reported Adverse Event.
Sanz-Navarro J; Feal C; Dauden E
Actas Dermosifiliogr; 2017 Sep; 108(7):643-649. PubMed ID: 28385424
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model.
Bernigaud C; Fang F; Fischer K; Lespine A; Aho LS; Dreau D; Kelly A; Sutra JF; Moreau F; Lilin T; Botterel F; Guillot J; Chosidow O
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005030. PubMed ID: 27732588
[TBL] [Abstract][Full Text] [Related]
11. Misuse of veterinary wormers in self-medication of rosacea and scabies.
Hellen R; Ní Raghallaigh S
Br J Dermatol; 2019 Apr; 180(4):955. PubMed ID: 30597520
[No Abstract] [Full Text] [Related]
12. Integrated assessment of ivermectin pharmacokinetics, efficacy against resistant Haemonchus contortus and P-glycoprotein expression in lambs treated at three different dosage levels.
Alvarez L; Suarez G; Ceballos L; Moreno L; Canton C; Lifschitz A; Maté L; Ballent M; Virkel G; Lanusse C
Vet Parasitol; 2015 May; 210(1-2):53-63. PubMed ID: 25841863
[TBL] [Abstract][Full Text] [Related]
13. Ivermectin: new indication. Oral treatment of scabies: simple and effective.
Prescrire Int; 2002 Oct; 11(61):137-40. PubMed ID: 12378743
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Pharmacokinetics Evaluation of a Single Oral Dose of Afoxolaner against Sarcoptes scabiei in the Porcine Scabies Model for Human Infestation.
Bernigaud C; Fang F; Fischer K; Lespine A; Aho LS; Mullins AJ; Tecle B; Kelly A; Sutra JF; Moreau F; Lilin T; Beugnet F; Botterel F; Chosidow O; Guillot J
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914951
[TBL] [Abstract][Full Text] [Related]
15. The effect of sesame and sunflower oils on the plasma disposition of ivermectin in goats.
Gokbulut C; Karademir U; Boyacioglu M; McKellar QA
J Vet Pharmacol Ther; 2008 Oct; 31(5):472-8. PubMed ID: 19000267
[TBL] [Abstract][Full Text] [Related]
16. Use of ivermectin for the management of scabies in a nursing home.
Dannaoui E; Kiazand A; Piens M; Picot S
Eur J Dermatol; 1999 Sep; 9(6):443-5. PubMed ID: 10491498
[TBL] [Abstract][Full Text] [Related]
17. Comparative depletion of ivermectin and moxidectin milk residues in dairy sheep after oral and subcutaneous administration.
Imperiale F; Lifschitz A; Sallovitz J; Virkel G; Lanusse C
J Dairy Res; 2004 Nov; 71(4):427-33. PubMed ID: 15605709
[TBL] [Abstract][Full Text] [Related]
18. Design of a Topically Applied Gel Spray Formulation with Ivermectin Using a Novel Low Molecular Weight Gelling Agent, Palmitoyl-Glycine-Histidine, to Treat Scabies.
Dahlizar S; Futaki M; Okada A; Kadhum WR; Todo H; Sugibayashi K
Chem Pharm Bull (Tokyo); 2018; 66(3):327-333. PubMed ID: 29491265
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pharmacokinetics and efficacy of ivermectin following oral administration in dogs against experimental infection of Ctenocephalides felis felis and Rhipicephalus sanguineus.
Magalhães VS; Cid YP; Ferreira TP; Medeiros DMV; de S O Batista LC; Correia TR; Albert ALM; Scott FB
Vet Parasitol; 2016 Sep; 228():167-171. PubMed ID: 27692320
[TBL] [Abstract][Full Text] [Related]
20. Comparative plasma disposition, bioavailability and efficacy of ivermectin following oral and pour-on administrations in horses.
Gokbulut C; Cirak VY; Senlik B; Aksit D; Durmaz M; McKellar QA
Vet Parasitol; 2010 May; 170(1-2):120-6. PubMed ID: 20181429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
